An Update on National Consensus Practice Guidelines for the Treatment of Hepatitis C & Literature Review in Epidemiology of Hepatitis C in Pakistan - 2022
Hepatitis C is a global health problem affecting around 58 million people worldwide and killing almost 0.29 million in on one year [1]. The world has united to fight against this lethal disease in 2016 with a moto to eliminate hepatitis by 2030. To achieve this goal WHO’s World Health Assembly has...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rawalpindi Medical University
2024-02-01
|
| Series: | Journal of Rawalpindi Medical College |
| Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/2533 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832086996371111936 |
|---|---|
| author | Sibt ul Hasnain Syed Muhammad Umar Hamama tul Bushra Khaar Tayyab Saeed Akhter Tassawar Hussain Amjad Salamat Syed Irfan Ahmad Rai Muhammad Asghar Muhammad Khurram Anwar A. Khan Fazl-e-Hadi Aftab Mohsin Waseem-Ud-Din Saleem Qureshi Sohail Iqbal Bhutta Javeria Zahid Khan Sadia Ahmad Aqsa Naseer Anum Abbas Misbah Noreen Faiza Aslam Zahid Mahmood Minhas Asif Abbas Naqvi Atifa Shoaib Saima Ambreen Gul Nisar Mohammad Mujeeb Khan Talal Khursheed Mohammad Osama |
| author_facet | Sibt ul Hasnain Syed Muhammad Umar Hamama tul Bushra Khaar Tayyab Saeed Akhter Tassawar Hussain Amjad Salamat Syed Irfan Ahmad Rai Muhammad Asghar Muhammad Khurram Anwar A. Khan Fazl-e-Hadi Aftab Mohsin Waseem-Ud-Din Saleem Qureshi Sohail Iqbal Bhutta Javeria Zahid Khan Sadia Ahmad Aqsa Naseer Anum Abbas Misbah Noreen Faiza Aslam Zahid Mahmood Minhas Asif Abbas Naqvi Atifa Shoaib Saima Ambreen Gul Nisar Mohammad Mujeeb Khan Talal Khursheed Mohammad Osama |
| author_sort | Sibt ul Hasnain Syed |
| collection | DOAJ |
| description |
Hepatitis C is a global health problem affecting around 58 million people worldwide and killing almost 0.29 million in on one year [1]. The world has united to fight against this lethal disease in 2016 with a moto to eliminate hepatitis by 2030. To achieve this goal WHO’s World Health Assembly has set some targets and individual countries have developed their own strategies to achieve those targets [2]. Pakistan has the 2nd highest prevalence of hepatitis C in the world with 5.8% viremia positive patients [3]. Pakistan is amongst the few countries that have been assisted by the Center for Disease Control and Prevention(CDC) to prevent and control Hepatitis[4].
With the availability of Direct Acting Antivirals(DAAs), the whole paradigm of treatment of hepatitis C has changed not only globally but also in Pakistan. However, the patients in Pakistan are unable to gain access to the latest DAAs at the pace, as they are available globally. International guidelines are being updated on regular basis as per global evidence, recommending such combinations which are not readily available to many parts of the world. Hence there is a dire need to develop national guidelines, keeping in consideration the efficacy of the drugs as well as their availability, in the broader canvas of achieving the targets of eliminating Hepatitis set by WHO.
In this context, our consensus guidelines are an effort to fill the gap created because of upgraded scientific evidence and possible combinations available in our part of the world. Furthermore, quite some good research and evidence has also been shared in the literature from Pakistan during last five years (2016-2021). Hence a literature review has also been carried out to update our own epidemiologic data, risk factors and treatment responses to Hepatitis C in Pakistan.
|
| format | Article |
| id | doaj-art-fbb2a20bc8f742d9859b0ae356e0c1d5 |
| institution | Kabale University |
| issn | 1683-3562 1683-3570 |
| language | English |
| publishDate | 2024-02-01 |
| publisher | Rawalpindi Medical University |
| record_format | Article |
| series | Journal of Rawalpindi Medical College |
| spelling | doaj-art-fbb2a20bc8f742d9859b0ae356e0c1d52025-02-06T08:39:42ZengRawalpindi Medical UniversityJournal of Rawalpindi Medical College1683-35621683-35702024-02-011110.37939/jrmc.v1i1.2533An Update on National Consensus Practice Guidelines for the Treatment of Hepatitis C & Literature Review in Epidemiology of Hepatitis C in Pakistan - 2022Sibt ul Hasnain SyedMuhammad UmarHamama tul Bushra KhaarTayyab Saeed AkhterTassawar HussainAmjad SalamatSyed Irfan AhmadRai Muhammad AsgharMuhammad KhurramAnwar A. KhanFazl-e-HadiAftab MohsinWaseem-Ud-DinSaleem QureshiSohail Iqbal BhuttaJaveria Zahid KhanSadia AhmadAqsa NaseerAnum AbbasMisbah NoreenFaiza AslamZahid Mahmood MinhasAsif Abbas NaqviAtifa ShoaibSaima AmbreenGul NisarMohammad Mujeeb KhanTalal KhursheedMohammad Osama Hepatitis C is a global health problem affecting around 58 million people worldwide and killing almost 0.29 million in on one year [1]. The world has united to fight against this lethal disease in 2016 with a moto to eliminate hepatitis by 2030. To achieve this goal WHO’s World Health Assembly has set some targets and individual countries have developed their own strategies to achieve those targets [2]. Pakistan has the 2nd highest prevalence of hepatitis C in the world with 5.8% viremia positive patients [3]. Pakistan is amongst the few countries that have been assisted by the Center for Disease Control and Prevention(CDC) to prevent and control Hepatitis[4]. With the availability of Direct Acting Antivirals(DAAs), the whole paradigm of treatment of hepatitis C has changed not only globally but also in Pakistan. However, the patients in Pakistan are unable to gain access to the latest DAAs at the pace, as they are available globally. International guidelines are being updated on regular basis as per global evidence, recommending such combinations which are not readily available to many parts of the world. Hence there is a dire need to develop national guidelines, keeping in consideration the efficacy of the drugs as well as their availability, in the broader canvas of achieving the targets of eliminating Hepatitis set by WHO. In this context, our consensus guidelines are an effort to fill the gap created because of upgraded scientific evidence and possible combinations available in our part of the world. Furthermore, quite some good research and evidence has also been shared in the literature from Pakistan during last five years (2016-2021). Hence a literature review has also been carried out to update our own epidemiologic data, risk factors and treatment responses to Hepatitis C in Pakistan. https://www.journalrmc.com/index.php/JRMC/article/view/2533 |
| spellingShingle | Sibt ul Hasnain Syed Muhammad Umar Hamama tul Bushra Khaar Tayyab Saeed Akhter Tassawar Hussain Amjad Salamat Syed Irfan Ahmad Rai Muhammad Asghar Muhammad Khurram Anwar A. Khan Fazl-e-Hadi Aftab Mohsin Waseem-Ud-Din Saleem Qureshi Sohail Iqbal Bhutta Javeria Zahid Khan Sadia Ahmad Aqsa Naseer Anum Abbas Misbah Noreen Faiza Aslam Zahid Mahmood Minhas Asif Abbas Naqvi Atifa Shoaib Saima Ambreen Gul Nisar Mohammad Mujeeb Khan Talal Khursheed Mohammad Osama An Update on National Consensus Practice Guidelines for the Treatment of Hepatitis C & Literature Review in Epidemiology of Hepatitis C in Pakistan - 2022 Journal of Rawalpindi Medical College |
| title | An Update on National Consensus Practice Guidelines for the Treatment of Hepatitis C & Literature Review in Epidemiology of Hepatitis C in Pakistan - 2022 |
| title_full | An Update on National Consensus Practice Guidelines for the Treatment of Hepatitis C & Literature Review in Epidemiology of Hepatitis C in Pakistan - 2022 |
| title_fullStr | An Update on National Consensus Practice Guidelines for the Treatment of Hepatitis C & Literature Review in Epidemiology of Hepatitis C in Pakistan - 2022 |
| title_full_unstemmed | An Update on National Consensus Practice Guidelines for the Treatment of Hepatitis C & Literature Review in Epidemiology of Hepatitis C in Pakistan - 2022 |
| title_short | An Update on National Consensus Practice Guidelines for the Treatment of Hepatitis C & Literature Review in Epidemiology of Hepatitis C in Pakistan - 2022 |
| title_sort | update on national consensus practice guidelines for the treatment of hepatitis c literature review in epidemiology of hepatitis c in pakistan 2022 |
| url | https://www.journalrmc.com/index.php/JRMC/article/view/2533 |
| work_keys_str_mv | AT sibtulhasnainsyed anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT muhammadumar anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT hamamatulbushrakhaar anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT tayyabsaeedakhter anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT tassawarhussain anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT amjadsalamat anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT syedirfanahmad anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT raimuhammadasghar anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT muhammadkhurram anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT anwarakhan anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT fazlehadi anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT aftabmohsin anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT waseemuddin anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT saleemqureshi anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT sohailiqbalbhutta anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT javeriazahidkhan anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT sadiaahmad anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT aqsanaseer anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT anumabbas anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT misbahnoreen anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT faizaaslam anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT zahidmahmoodminhas anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT asifabbasnaqvi anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT atifashoaib anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT saimaambreen anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT gulnisar anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT mohammadmujeebkhan anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT talalkhursheed anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT mohammadosama anupdateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT sibtulhasnainsyed updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT muhammadumar updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT hamamatulbushrakhaar updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT tayyabsaeedakhter updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT tassawarhussain updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT amjadsalamat updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT syedirfanahmad updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT raimuhammadasghar updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT muhammadkhurram updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT anwarakhan updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT fazlehadi updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT aftabmohsin updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT waseemuddin updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT saleemqureshi updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT sohailiqbalbhutta updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT javeriazahidkhan updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT sadiaahmad updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT aqsanaseer updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT anumabbas updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT misbahnoreen updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT faizaaslam updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT zahidmahmoodminhas updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT asifabbasnaqvi updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT atifashoaib updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT saimaambreen updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT gulnisar updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT mohammadmujeebkhan updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT talalkhursheed updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 AT mohammadosama updateonnationalconsensuspracticeguidelinesforthetreatmentofhepatitiscliteraturereviewinepidemiologyofhepatitiscinpakistan2022 |